Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| OMEROS CORPOMER · Entity 4756 | VP Patent and General Counsel | June 07, 2019 | June 11, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
OMEROS CORP
Report date June 07, 2019 · Filed June 11, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 210,645 |
Reported balance
After 2019-06-07 transaction · row 1
1 source rowRow 1 · 2019-06-07 · Exercise / conversion · Acquired 10,000 · Balance 210,645 |
| Stock Option (Righ to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.05 · Expires 2020-03-28 | Direct | 43,996 |
Reported balance
After 2019-06-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-06-07 · Exercise / conversion · Disposed 10,000 · Balance 43,996 F1: On June 7, 2019, the reporting person paid the exercise price and exercised options to purchase 10,000 shares of the issuer's common stock. The shares have not been sold and the reporting person does not expect to sell the shares for the foreseeable future. The options previously vested and became exercisable in 48 equal monthly installments, with a vesting commencement date of April 1, 2010. |
Filing footnotes · ownership attribution and instrument terms
F1: On June 7, 2019, the reporting person paid the exercise price and exercised options to purchase 10,000 shares of the issuer's common stock. The shares have not been sold and the reporting person does not expect to sell the shares for the foreseeable future. The options previously vested and became exercisable in 48 equal monthly installments, with a vesting commencement date of April 1, 2010.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 07, 2019 Filed Jun 11, 2019 18:51 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (Righ to Buy) · Derivative | 10,000 | $0.00 Strike: $6.05 | $0.00 |
DisclosureSEC source: 0000899243-19-016488 · doc4.xml · derivative · entry 2 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,996 Underlying: Common Stock · 10,000 shares Expires 2020-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On June 7, 2019, the reporting person paid the exercise price and exercised options to purchase 10,000 shares of the issuer's common stock. The shares have not been sold and the reporting person does not expect to sell the shares for the foreseeable future. The options previously vested and became exercisable in 48 equal monthly installments, with a vesting commencement date of April 1, 2010. Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 18:51 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 10,000 | $6.05 | $60,500.00 |
DisclosureSEC source: 0000899243-19-016488 · doc4.xml · nonDerivative · entry 1 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 20:55 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (right to buy) · Derivative | 65,000 | $0.00 Strike: $13.45 | $0.00 |
DisclosureSEC source: 0000899243-19-003367 · doc4.xml · derivative · entry 1 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2029-02-07 F1 · derivative.exercise_date: This option vests and becomes exercisable over 48 equal monthly installments, with a vesting commencement date of February 8, 2019. Installments vest and become exercisable on each monthly anniversary thereafter. Read SEC document |
| August 31, 2018 Filed Aug 31, 2018 21:32 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $6.05 | $0.00 |
DisclosureSEC source: 0000899243-18-023667 · doc4.xml · derivative · entry 9 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,996 Underlying: Common Stock · 8,000 shares Expires 2020-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: On August 31, 2018, the reporting person paid the exercise price and exercised options to purchase 8,000 shares of the company's common stock. The shares have not been sold and are held for the account of the reporting person. The options previously vested and became exercisable in 48 equal monthly installments, with a vesting commencement date of April 1, 2010. Read SEC document |
| August 31, 2018 Filed Aug 31, 2018 21:32 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,529 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0000899243-18-023667 · doc4.xml · derivative · entry 8 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,529 shares Expires 2022-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested and became exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2011. Read SEC document |
| August 31, 2018 Filed Aug 31, 2018 21:32 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 8,000 | $6.05 | $48,400.00 |
DisclosureSEC source: 0000899243-18-023667 · doc4.xml · nonDerivative · entry 6 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2018 Filed Aug 31, 2018 21:32 UTC | OMEROS CORP OMER · Entity 4756 | SaleCommon Stock | 5,337 | $25.93 | $138,376.13 |
DisclosureSEC source: 0000899243-18-023667 · doc4.xml · nonDerivative · entry 5 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,645 F1 · kind: Open market sale pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. The trading schedule, including sale periods, price and the number of shares to be sold, was established in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The sale was planned in advance for purposes including funding ongoing home construction and the exercise and holding of certain Omeros options. F3 · price: This transaction was executed in multiple trades at prices ranging from $25.76 to $26.18; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| August 31, 2018 Filed Aug 31, 2018 21:32 UTC | OMEROS CORP OMER · Entity 4756 | SaleCommon Stock | 2,192 | $25.31 | $55,469.44 |
DisclosureSEC source: 0000899243-18-023667 · doc4.xml · nonDerivative · entry 4 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,982 F1 · kind: Open market sale pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. The trading schedule, including sale periods, price and the number of shares to be sold, was established in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The sale was planned in advance for purposes including funding ongoing home construction and the exercise and holding of certain Omeros options. F2 · price: This transaction was executed in multiple trades at prices ranging from $24.76 to $25.72; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| August 31, 2018 Filed Aug 31, 2018 21:32 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 7,529 | $4.10 | $30,868.90 |
DisclosureSEC source: 0000899243-18-023667 · doc4.xml · nonDerivative · entry 3 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,174 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 30, 2018 Filed Aug 31, 2018 21:32 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0000899243-18-023667 · doc4.xml · derivative · entry 7 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,529 Underlying: Common Stock · 35,000 shares Expires 2022-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested and became exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2011. Read SEC document |
| August 30, 2018 Filed Aug 31, 2018 21:32 UTC | OMEROS CORP OMER · Entity 4756 | SaleCommon Stock | 35,000 | $24.45 | $855,750.00 |
DisclosureSEC source: 0000899243-18-023667 · doc4.xml · nonDerivative · entry 2 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,645 F1 · kind: Open market sale pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. The trading schedule, including sale periods, price and the number of shares to be sold, was established in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The sale was planned in advance for purposes including funding ongoing home construction and the exercise and holding of certain Omeros options. Read SEC document |
| August 30, 2018 Filed Aug 31, 2018 21:32 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 35,000 | $4.10 | $143,500.00 |
DisclosureSEC source: 0000899243-18-023667 · doc4.xml · nonDerivative · entry 1 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2018 Filed Jul 30, 2018 19:00 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,723 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0000899243-18-020780 · doc4.xml · derivative · entry 8 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,529 Underlying: Common Stock · 35,000 shares Expires 2022-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested and became exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2011. Read SEC document |
| July 27, 2018 Filed Jul 30, 2018 19:00 UTC | OMEROS CORP OMER · Entity 4756 | SaleCommon Stock | 5,723 | $21.73 | $124,356.78 |
DisclosureSEC source: 0000899243-18-020780 · doc4.xml · nonDerivative · entry 5 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,645 F1 · kind: Open market sale pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. The trading schedule, including sale periods, price and the number of shares to be sold, was established in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The sale was planned in advance for purposes including funding ongoing home construction and the exercise and holding of certain Omeros options. F3 · price: This transaction was executed in multiple trades at prices ranging from $21.48 to $21.90; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| July 27, 2018 Filed Jul 30, 2018 19:00 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 5,723 | $4.10 | $23,464.30 |
DisclosureSEC source: 0000899243-18-020780 · doc4.xml · nonDerivative · entry 4 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,368 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 19:00 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $6.05 | $0.00 |
DisclosureSEC source: 0000899243-18-020780 · doc4.xml · derivative · entry 7 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,996 Underlying: Common Stock · 8,000 shares Expires 2020-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: On July 26, 2018, the reporting person paid the exercise price and exercised options to purchase 8,000 shares of the company's common stock. The shares have not been sold and are held for the account of the reporting person. The options previously vested and became exercisable in 48 equal monthly installments, with a vesting commencement date of April 1, 2010. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 19:00 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0000899243-18-020780 · doc4.xml · derivative · entry 6 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,252 Underlying: Common Stock · 35,000 shares Expires 2022-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested and became exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2011. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 19:00 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 8,000 | $6.05 | $48,400.00 |
DisclosureSEC source: 0000899243-18-020780 · doc4.xml · nonDerivative · entry 3 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 19:00 UTC | OMEROS CORP OMER · Entity 4756 | SaleCommon Stock | 35,000 | $21.53 | $753,686.50 |
DisclosureSEC source: 0000899243-18-020780 · doc4.xml · nonDerivative · entry 2 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,645 F1 · kind: Open market sale pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. The trading schedule, including sale periods, price and the number of shares to be sold, was established in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The sale was planned in advance for purposes including funding ongoing home construction and the exercise and holding of certain Omeros options. F2 · price: This transaction was executed in multiple trades at prices ranging from $21.45 to $21.63; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 19:00 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 35,000 | $4.10 | $143,500.00 |
DisclosureSEC source: 0000899243-18-020780 · doc4.xml · nonDerivative · entry 1 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 12, 2018 Filed Jul 13, 2018 20:00 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,277 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0000899243-18-019862 · doc4.xml · derivative · entry 3 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,252 Underlying: Common Stock · 4,277 shares Expires 2022-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested and became exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2011. Read SEC document |
| July 12, 2018 Filed Jul 13, 2018 20:00 UTC | OMEROS CORP OMER · Entity 4756 | SaleCommon Stock | 4,277 | $21.48 | $91,886.21 |
DisclosureSEC source: 0000899243-18-019862 · doc4.xml · nonDerivative · entry 2 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,645 F1 · kind: Open market sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2017, and amended on May 17, 2018. The trading schedule, including sale periods, price and the number of shares to be sold, was established in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · price: This transaction was executed in multiple trades at prices ranging from $21.46 to $21.49; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| July 12, 2018 Filed Jul 13, 2018 20:00 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 4,277 | $4.10 | $17,535.70 |
DisclosureSEC source: 0000899243-18-019862 · doc4.xml · nonDerivative · entry 1 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,922 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 08, 2018 Filed Apr 10, 2018 20:00 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $13.58 | $0.00 |
DisclosureSEC source: 0000899243-18-009872 · doc4.xml · derivative · entry 1 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2028-04-07 F1 · derivative.exercise_date: The option vests and becomes exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2018. Installments vest and become exercisable on each monthly anniversary thereafter. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 20:00 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,004 | $0.00 Strike: $6.05 | $0.00 |
DisclosureSEC source: 0000899243-18-000629 · doc4.xml · derivative · entry 7 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,996 Underlying: Common Stock · 5,004 shares Expires 2020-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On January 3, 2018, the reporting person paid the exercise price and exercised options to purchase 5,004 shares of the company's common stock. These shares have not been sold and are held for the account of the reporting person. The options previously vested and became exercisable in 48 equal monthly installments, with a vesting commencement date of April 1, 2010. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 20:00 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $6.05 | $0.00 |
DisclosureSEC source: 0000899243-18-000629 · doc4.xml · derivative · entry 6 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2020-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On January 3, 2018, the reporting person paid the exercise price and exercised options to purchase 3,000 shares of the company's common stock. These shares have not been sold and are held for the account of the reporting person. The options previously vested and became exercisable in 48 equal monthly installments, with a vesting commencement date of November 1, 2009. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 20:00 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (Right to Buy) · Derivative | 62,528 | $0.00 Strike: $9.37 | $0.00 |
DisclosureSEC source: 0000899243-18-000629 · doc4.xml · derivative · entry 5 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,972 Underlying: Common Stock · 62,528 shares Expires 2023-09-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options previously vested and became exercisable in 48 equal monthly installments, with a vesting commencement date of April 1, 2013. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 20:00 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 5,004 | $6.05 | $30,274.20 |
DisclosureSEC source: 0000899243-18-000629 · doc4.xml · nonDerivative · entry 4 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 20:00 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 3,000 | $6.05 | $18,150.00 |
DisclosureSEC source: 0000899243-18-000629 · doc4.xml · nonDerivative · entry 3 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 20:00 UTC | OMEROS CORP OMER · Entity 4756 | SaleCommon Stock | 62,528 | $21.45 | $1,341,225.60 |
DisclosureSEC source: 0000899243-18-000629 · doc4.xml · nonDerivative · entry 2 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,641 F1 · kind: Open market sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2017, at which time the trading schedule, including sale periods, price and the number of shares to be sold, was established in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 20:00 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 62,528 | $9.37 | $585,887.36 |
DisclosureSEC source: 0000899243-18-000629 · doc4.xml · nonDerivative · entry 1 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,169 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 21, 2017 Filed Aug 21, 2017 15:21 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $6.05 | $0.00 |
DisclosureSEC source: 0000899243-17-020739 · doc4.xml · derivative · entry 2 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 8,000 shares Expires 2020-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On August 21, 2017, the reporting person paid the exercise price and exercised options to purchase 8,000 shares of the company's common stock and held the shares for her account; these shares have not been sold. The options previously vested and became exercisable in 48 equal monthly installments, with a vesting commencement date of April 1, 2010. Read SEC document |
| August 21, 2017 Filed Aug 21, 2017 15:21 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 8,000 | $6.05 | $48,400.00 |
DisclosureSEC source: 0000899243-17-020739 · doc4.xml · nonDerivative · entry 1 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 16:06 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,040 | $0.00 Strike: $6.05 | $0.00 |
DisclosureSEC source: 0000899243-17-008378 · doc4.xml · derivative · entry 2 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 2,040 shares Expires 2020-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On March 20, 2017, the reporting person paid the exercise price and exercised options to purchase 2,040 shares of the company's common stock and held the shares for her account; these shares have not been sold. The options previously vested and became exercisable in 48 equal monthly installments, with a vesting commencement date of April 1, 2010. Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 16:06 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 2,040 | $6.05 | $12,342.00 |
DisclosureSEC source: 0000899243-17-008378 · doc4.xml · nonDerivative · entry 1 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2017 Filed Feb 28, 2017 20:00 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $11.55 | $0.00 |
DisclosureSEC source: 0000899243-17-005672 · doc4.xml · derivative · entry 1 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2027-02-25 F1 · derivative.exercise_date: The option vests and becomes exercisable over 48 equal monthly installments, with a vesting commencement date of February 26, 2017. Installments vest and become exercisable on each monthly anniversary thereafter. Read SEC document |
| December 05, 2016 Filed Dec 7, 2016 21:00 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $10.56 | $0.00 |
DisclosureSEC source: 0000899243-16-035088 · doc4.xml · derivative · entry 1 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2026-12-04 F1 · derivative.exercise_date: The option vests and becomes exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2016. Installments vest and become exercisable on each monthly anniversary thereafter. Read SEC document |
| October 12, 2016 Filed Oct 12, 2016 21:00 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,004 | $0.00 Strike: $6.05 | $0.00 |
DisclosureSEC source: 0000899243-16-031631 · doc4.xml · derivative · entry 2 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,040 Underlying: Common Stock · 3,004 shares Expires 2020-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested and became exercisable in 48 equal monthly installments, with a vesting commencement date of April 1, 2010. Installments vested and became exercisable on each monthly anniversary thereafter. On October 12, 2016, the reporting person exercised options to purchase 3,004 of these shares and held such shares for her account. Read SEC document |
| October 12, 2016 Filed Oct 12, 2016 21:00 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 3,004 | $6.05 | $18,174.20 |
DisclosureSEC source: 0000899243-16-031631 · doc4.xml · nonDerivative · entry 1 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,601 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2016 Filed Sep 16, 2016 20:00 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $0.98 | $0.00 |
DisclosureSEC source: 0000899243-16-029181 · doc4.xml · derivative · entry 3 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,000 shares Expires 2016-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested and became exercisable in 48 equal monthly installments. The first installment became exercisable on November 1, 2005 and subsequent installments became exercisable on each monthly anniversary thereafter. Read SEC document |
| September 15, 2016 Filed Sep 16, 2016 20:00 UTC | OMEROS CORP OMER · Entity 4756 | SaleCommon Stock | 16,000 | $10.91 | $174,577.60 |
DisclosureSEC source: 0000899243-16-029181 · doc4.xml · nonDerivative · entry 2 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,597 F1 · kind: Open market sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2014, and amended on May 13, 2016, which provided for the exercise and sale of options to purchase 175,000 shares of common stock that expire on December 11, 2016. The May 13, 2016 amendment to Ms. Kelbon's trading plan provided for the future exercise and sale of certain other series of the issuer's stock options. Under the plan, the options expiring on December 11, 2016 would be exercised and sold at fixed sale periods, price and numbers set at the time the plan was adopted in 2014 over a one-year period beginning in November 2015, with sale periods commencing approximately monthly and with approximately 15,900 such options to be exercised and sold in each sale period. This sale was the last scheduled sale of options expiring in 2016 under the plan. Consistent with applicable trading rules, Ms. Kelbon has had no further control over the terms or timing of sales under the plan. F2 · kind: (Continued from Footnote 1) A portion of the proceeds from the exercise of the options expiring on December 11, 2016 are being used to fund Ms. Kelbon's exercise of other series of the issuer's stock options and retention of the underlying shares, and may also be used to fund the payment of taxes incurred by the exercise of such options. F3 · price: This transaction was executed in multiple trades at prices ranging from $10.69 to $11.08; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| September 15, 2016 Filed Sep 16, 2016 20:00 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 16,000 | $0.98 | $15,680.00 |
DisclosureSEC source: 0000899243-16-029181 · doc4.xml · nonDerivative · entry 1 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,597 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.